Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-02

Clinical Trial Update: Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol [NA]

View source ↗

Summary

Completed clinical trial comparing meglumine antimoniate alone versus combination therapy with allopurinol for cutaneous leishmaniasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)
  • Meglumine antimoniate (meglumine antimoniate)

Snippet

Sponsor: Combined Military Hospital, Pakistan | Conditions: Leishmaniasis, Cutaneous | NA | Status: COMPLETED